 | • レポートコード：MRC2Q12-19275 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ニフェジピンAPIのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ニフェジピンAPIのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ニフェジピンAPIの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ニフェジピンAPIのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのニフェジピンAPIの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のニフェジピンAPIの売上および2028年までの予測に焦点を当てています。 ニフェジピンAPIのグローバル主要企業には、Dipharma Francis S.r.l、Yantai Luyin Pharmaceutical、Delmar Chemicals Inc.、Cipla Ltd、Xiyue Pharmaceutical、Teva Pharmaceuticals、Zhong'an Pharmaceutical、Siyao Pharmaceuticals、Qingyang Pharmaceutical、Bayer AG、Sumika Fine Chemicals Co. Ltd.、Tecoland Corp、Moehs Iberica S.L.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ニフェジピンAPI市場は、タイプとアプリケーションによって区分されます。世界のニフェジピンAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 98% ニフェジピン API、99% ニフェジピン API、99.9% ニフェジピン API 【アプリケーション別セグメント】 ニフェジピン徐放錠、ニフェジピン徐放錠 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ニフェジピンAPI製品概要 - タイプ別市場（98% ニフェジピン API、99% ニフェジピン API、99.9% ニフェジピン API） - アプリケーション別市場（ニフェジピン徐放錠、ニフェジピン徐放錠） - 調査の目的 ・エグゼクティブサマリー - 世界のニフェジピンAPI販売量予測2017-2028 - 世界のニフェジピンAPI売上予測2017-2028 - ニフェジピンAPIの地域別販売量 - ニフェジピンAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ニフェジピンAPI販売量 - 主要メーカー別ニフェジピンAPI売上 - 主要メーカー別ニフェジピンAPI価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（98% ニフェジピン API、99% ニフェジピン API、99.9% ニフェジピン API） - ニフェジピンAPIのタイプ別販売量 - ニフェジピンAPIのタイプ別売上 - ニフェジピンAPIのタイプ別価格 ・アプリケーション別市場規模（ニフェジピン徐放錠、ニフェジピン徐放錠） - ニフェジピンAPIのアプリケーション別販売量 - ニフェジピンAPIのアプリケーション別売上 - ニフェジピンAPIのアプリケーション別価格 ・北米市場 - 北米のニフェジピンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のニフェジピンAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのニフェジピンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のニフェジピンAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のニフェジピンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のニフェジピンAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のニフェジピンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のニフェジピンAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのニフェジピンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のニフェジピンAPI市場規模（トルコ、サウジアラビア） ・企業情報 Dipharma Francis S.r.l、Yantai Luyin Pharmaceutical、Delmar Chemicals Inc.、Cipla Ltd、Xiyue Pharmaceutical、Teva Pharmaceuticals、Zhong'an Pharmaceutical、Siyao Pharmaceuticals、Qingyang Pharmaceutical、Bayer AG、Sumika Fine Chemicals Co. Ltd.、Tecoland Corp、Moehs Iberica S.L. ・産業チェーン及び販売チャネル分析 - ニフェジピンAPIの産業チェーン分析 - ニフェジピンAPIの原材料 - ニフェジピンAPIの生産プロセス - ニフェジピンAPIの販売及びマーケティング - ニフェジピンAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ニフェジピンAPIの産業動向 - ニフェジピンAPIのマーケットドライバー - ニフェジピンAPIの課題 - ニフェジピンAPIの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Nifedipine API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Nifedipine API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Nifedipine API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Nifedipine API include Dipharma Francis S.r.l, Yantai Luyin Pharmaceutical, Delmar Chemicals Inc., Cipla Ltd, Xiyue Pharmaceutical, Teva Pharmaceuticals, Zhong’an Pharmaceutical, Siyao Pharmaceuticals and Qingyang Pharmaceutical, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Nifedipine API manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Nifedipine API market. Further, it explains the major drivers and regional dynamics of the global Nifedipine API market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Dipharma Francis S.r.l
Yantai Luyin Pharmaceutical
Delmar Chemicals Inc.
Cipla Ltd
Xiyue Pharmaceutical
Teva Pharmaceuticals
Zhong’an Pharmaceutical
Siyao Pharmaceuticals
Qingyang Pharmaceutical
Bayer AG
Sumika Fine Chemicals Co. Ltd.
Tecoland Corp
Moehs Iberica S.L.
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Nifedipine API Segment by Type
98% Nifedipine API
99% Nifedipine API
99.9% Nifedipine API
Nifedipine API Segment by Application
Nifedipine Controlled Release Tablets
Nifedipine Extended Release Tablets
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Nifedipine API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Nifedipine API, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Nifedipine API, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Nifedipine API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nifedipine API sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Nifedipine API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Nifedipine API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Dipharma Francis S.r.l, Yantai Luyin Pharmaceutical, Delmar Chemicals Inc., Cipla Ltd, Xiyue Pharmaceutical, Teva Pharmaceuticals, Zhong’an Pharmaceutical, Siyao Pharmaceuticals and Qingyang Pharmaceutical, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Nifedipine API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Nifedipine API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nifedipine API sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Nifedipine API Product Introduction
1.2 Market by Type
1.2.1 Global Nifedipine API Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 98% Nifedipine API
1.2.3 99% Nifedipine API
1.2.4 99.9% Nifedipine API
1.3 Market by Application
1.3.1 Global Nifedipine API Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Nifedipine Controlled Release Tablets
1.3.3 Nifedipine Extended Release Tablets
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nifedipine API Sales Estimates and Forecasts 2017-2028
2.2 Global Nifedipine API Revenue Estimates and Forecasts 2017-2028
2.3 Global Nifedipine API Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Nifedipine API Sales by Region
2.4.1 Global Nifedipine API Sales by Region (2017-2022)
2.4.2 Global Sales Nifedipine API by Region (2023-2028)
2.5 Global Nifedipine API Revenue by Region
2.5.1 Global Nifedipine API Revenue by Region (2017-2022)
2.5.2 Global Nifedipine API Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Nifedipine API Sales by Manufacturers
3.1.1 Global Top Nifedipine API Manufacturers by Sales (2017-2022)
3.1.2 Global Nifedipine API Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nifedipine API in 2021
3.2 Global Nifedipine API Revenue by Manufacturers
3.2.1 Global Nifedipine API Revenue by Manufacturers (2017-2022)
3.2.2 Global Nifedipine API Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Nifedipine API Revenue in 2021
3.3 Global Nifedipine API Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nifedipine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nifedipine API Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nifedipine API Sales by Type
4.1.1 Global Nifedipine API Historical Sales by Type (2017-2022)
4.1.2 Global Nifedipine API Forecasted Sales by Type (2023-2028)
4.1.3 Global Nifedipine API Sales Market Share by Type (2017-2028)
4.2 Global Nifedipine API Revenue by Type
4.2.1 Global Nifedipine API Historical Revenue by Type (2017-2022)
4.2.2 Global Nifedipine API Forecasted Revenue by Type (2023-2028)
4.2.3 Global Nifedipine API Revenue Market Share by Type (2017-2028)
4.3 Global Nifedipine API Price by Type
4.3.1 Global Nifedipine API Price by Type (2017-2022)
4.3.2 Global Nifedipine API Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Nifedipine API Sales by Application
5.1.1 Global Nifedipine API Historical Sales by Application (2017-2022)
5.1.2 Global Nifedipine API Forecasted Sales by Application (2023-2028)
5.1.3 Global Nifedipine API Sales Market Share by Application (2017-2028)
5.2 Global Nifedipine API Revenue by Application
5.2.1 Global Nifedipine API Historical Revenue by Application (2017-2022)
5.2.2 Global Nifedipine API Forecasted Revenue by Application (2023-2028)
5.2.3 Global Nifedipine API Revenue Market Share by Application (2017-2028)
5.3 Global Nifedipine API Price by Application
5.3.1 Global Nifedipine API Price by Application (2017-2022)
5.3.2 Global Nifedipine API Price Forecast by Application (2023-2028)
6 North America
6.1 North America Nifedipine API Market Size by Type
6.1.1 North America Nifedipine API Sales by Type (2017-2028)
6.1.2 North America Nifedipine API Revenue by Type (2017-2028)
6.2 North America Nifedipine API Market Size by Application
6.2.1 North America Nifedipine API Sales by Application (2017-2028)
6.2.2 North America Nifedipine API Revenue by Application (2017-2028)
6.3 North America Nifedipine API Market Size by Country
6.3.1 North America Nifedipine API Sales by Country (2017-2028)
6.3.2 North America Nifedipine API Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Nifedipine API Market Size by Type
7.1.1 Europe Nifedipine API Sales by Type (2017-2028)
7.1.2 Europe Nifedipine API Revenue by Type (2017-2028)
7.2 Europe Nifedipine API Market Size by Application
7.2.1 Europe Nifedipine API Sales by Application (2017-2028)
7.2.2 Europe Nifedipine API Revenue by Application (2017-2028)
7.3 Europe Nifedipine API Market Size by Country
7.3.1 Europe Nifedipine API Sales by Country (2017-2028)
7.3.2 Europe Nifedipine API Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nifedipine API Market Size by Type
8.1.1 Asia Pacific Nifedipine API Sales by Type (2017-2028)
8.1.2 Asia Pacific Nifedipine API Revenue by Type (2017-2028)
8.2 Asia Pacific Nifedipine API Market Size by Application
8.2.1 Asia Pacific Nifedipine API Sales by Application (2017-2028)
8.2.2 Asia Pacific Nifedipine API Revenue by Application (2017-2028)
8.3 Asia Pacific Nifedipine API Market Size by Region
8.3.1 Asia Pacific Nifedipine API Sales by Region (2017-2028)
8.3.2 Asia Pacific Nifedipine API Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Nifedipine API Market Size by Type
9.1.1 Latin America Nifedipine API Sales by Type (2017-2028)
9.1.2 Latin America Nifedipine API Revenue by Type (2017-2028)
9.2 Latin America Nifedipine API Market Size by Application
9.2.1 Latin America Nifedipine API Sales by Application (2017-2028)
9.2.2 Latin America Nifedipine API Revenue by Application (2017-2028)
9.3 Latin America Nifedipine API Market Size by Country
9.3.1 Latin America Nifedipine API Sales by Country (2017-2028)
9.3.2 Latin America Nifedipine API Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Nifedipine API Market Size by Type
10.1.1 Middle East and Africa Nifedipine API Sales by Type (2017-2028)
10.1.2 Middle East and Africa Nifedipine API Revenue by Type (2017-2028)
10.2 Middle East and Africa Nifedipine API Market Size by Application
10.2.1 Middle East and Africa Nifedipine API Sales by Application (2017-2028)
10.2.2 Middle East and Africa Nifedipine API Revenue by Application (2017-2028)
10.3 Middle East and Africa Nifedipine API Market Size by Country
10.3.1 Middle East and Africa Nifedipine API Sales by Country (2017-2028)
10.3.2 Middle East and Africa Nifedipine API Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Dipharma Francis S.r.l
11.1.1 Dipharma Francis S.r.l Corporation Information
11.1.2 Dipharma Francis S.r.l Overview
11.1.3 Dipharma Francis S.r.l Nifedipine API Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Dipharma Francis S.r.l Nifedipine API Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Dipharma Francis S.r.l Recent Developments
11.2 Yantai Luyin Pharmaceutical
11.2.1 Yantai Luyin Pharmaceutical Corporation Information
11.2.2 Yantai Luyin Pharmaceutical Overview
11.2.3 Yantai Luyin Pharmaceutical Nifedipine API Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Yantai Luyin Pharmaceutical Nifedipine API Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Yantai Luyin Pharmaceutical Recent Developments
11.3 Delmar Chemicals Inc.
11.3.1 Delmar Chemicals Inc. Corporation Information
11.3.2 Delmar Chemicals Inc. Overview
11.3.3 Delmar Chemicals Inc. Nifedipine API Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Delmar Chemicals Inc. Nifedipine API Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Delmar Chemicals Inc. Recent Developments
11.4 Cipla Ltd
11.4.1 Cipla Ltd Corporation Information
11.4.2 Cipla Ltd Overview
11.4.3 Cipla Ltd Nifedipine API Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Cipla Ltd Nifedipine API Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cipla Ltd Recent Developments
11.5 Xiyue Pharmaceutical
11.5.1 Xiyue Pharmaceutical Corporation Information
11.5.2 Xiyue Pharmaceutical Overview
11.5.3 Xiyue Pharmaceutical Nifedipine API Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Xiyue Pharmaceutical Nifedipine API Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Xiyue Pharmaceutical Recent Developments
11.6 Teva Pharmaceuticals
11.6.1 Teva Pharmaceuticals Corporation Information
11.6.2 Teva Pharmaceuticals Overview
11.6.3 Teva Pharmaceuticals Nifedipine API Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Pharmaceuticals Nifedipine API Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharmaceuticals Recent Developments
11.7 Zhong’an Pharmaceutical
11.7.1 Zhong’an Pharmaceutical Corporation Information
11.7.2 Zhong’an Pharmaceutical Overview
11.7.3 Zhong’an Pharmaceutical Nifedipine API Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Zhong’an Pharmaceutical Nifedipine API Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Zhong’an Pharmaceutical Recent Developments
11.8 Siyao Pharmaceuticals
11.8.1 Siyao Pharmaceuticals Corporation Information
11.8.2 Siyao Pharmaceuticals Overview
11.8.3 Siyao Pharmaceuticals Nifedipine API Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Siyao Pharmaceuticals Nifedipine API Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Siyao Pharmaceuticals Recent Developments
11.9 Qingyang Pharmaceutical
11.9.1 Qingyang Pharmaceutical Corporation Information
11.9.2 Qingyang Pharmaceutical Overview
11.9.3 Qingyang Pharmaceutical Nifedipine API Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Qingyang Pharmaceutical Nifedipine API Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Qingyang Pharmaceutical Recent Developments
11.10 Bayer AG
11.10.1 Bayer AG Corporation Information
11.10.2 Bayer AG Overview
11.10.3 Bayer AG Nifedipine API Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Bayer AG Nifedipine API Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bayer AG Recent Developments
11.11 Sumika Fine Chemicals Co. Ltd.
11.11.1 Sumika Fine Chemicals Co. Ltd. Corporation Information
11.11.2 Sumika Fine Chemicals Co. Ltd. Overview
11.11.3 Sumika Fine Chemicals Co. Ltd. Nifedipine API Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sumika Fine Chemicals Co. Ltd. Nifedipine API Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sumika Fine Chemicals Co. Ltd. Recent Developments
11.12 Tecoland Corp
11.12.1 Tecoland Corp Corporation Information
11.12.2 Tecoland Corp Overview
11.12.3 Tecoland Corp Nifedipine API Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Tecoland Corp Nifedipine API Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Tecoland Corp Recent Developments
11.13 Moehs Iberica S.L.
11.13.1 Moehs Iberica S.L. Corporation Information
11.13.2 Moehs Iberica S.L. Overview
11.13.3 Moehs Iberica S.L. Nifedipine API Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Moehs Iberica S.L. Nifedipine API Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Moehs Iberica S.L. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nifedipine API Industry Chain Analysis
12.2 Nifedipine API Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nifedipine API Production Mode & Process
12.4 Nifedipine API Sales and Marketing
12.4.1 Nifedipine API Sales Channels
12.4.2 Nifedipine API Distributors
12.5 Nifedipine API Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nifedipine API Industry Trends
13.2 Nifedipine API Market Drivers
13.3 Nifedipine API Market Challenges
13.4 Nifedipine API Market Restraints
14 Key Findings in The Global Nifedipine API Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer